Efficacy of the HPV-16/18 Vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 Vaccine Trial

Por Hildesheim, Allan, Wacholder, Sholom, Catteau, Gregory, Struyf, Frank, Dubin, Gary, Herrero, Rolando
Publicado em 2014

Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15–55 years

Por Schwarz, Tino F, Spaczynski, Marek, Schneider, Achim, Wysocki, Jacek, Galaj, Andrzej, Schulze, Karin, Poncelet, Sylviane, Catteau, Gregory, Thomas, Florence, Descamps, Dominique
Publicado em 2011

Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18–45 years:...

Por Einstein, Mark H, Levin, Myron J, Chatterjee, Archana, Chakhtoura, Nahida, Takacs, Peter, Catteau, Grégory, Dessy, Francis J, Moris, Philippe, Lin, Lan, Struyf, Frank, Dubin, Gary
Publicado no Hum Vaccin Immunother (2014)

1956. Persistence of Immune Response and Safety of an Adjuvanted Recombinant Zoster Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: End-...

Por Mrkvan, Tomas, Campora, Laura, Catteau, Grégory, Douha, Martine, Grupping, Katrijn, Herve, Caroline, Kalema, George, Heineman, Thomas, Klein, Nicola P, Lal, Himal, Oostvogels, Lidia, Schuind, Anne
Publicado no Open Forum Infect Dis (2018)

Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: Results from a randomized study

Por Romanowski, Barbara, Schwarz, Tino F, Ferguson, Linda M, Peters, Klaus, Dionne, Marc, Schulze, Karin, Ramjattan, Brian, Hillemanns, Peter, Catteau, Grégory, Dobbelaere, Kurt, Schuind, Anne, Descamps, Dominique
Publicado em 2011

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: Final analysis of a long-term follow-up study up to 9.4 years post-vaccination

Por Naud, Paulo S, Roteli-Martins, Cecilia M, De Carvalho, Newton S, Teixeira, Julio C, de Borba, Paola C, Sanchez, Nervo, Zahaf, Toufik, Catteau, Gregory, Geeraerts, Brecht, Descamps, Dominique
Publicado no Hum Vaccin Immunother (2014)

2905. Long-term Immunological Persistence of the Adjuvanted Recombinant Zoster Vaccine: Clinical Data and Mathematical Modeling

Por Bastidas, Adriana, Catteau, Grégory, Volpe, Stéphanie, Mrkvan, Tomas, Enemuo, Adaora, Smetana, Jan, Schwarz, Tino, Rombo, Lars, Pauksens, Karlis, Berengier, Estelle, Hervé, Caroline, Oostvogels, Lidia, Schuind, Anne
Publicado no Open Forum Infect Dis (2019)

Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults

Por Schwarz, Tino F., Volpe, Stephanie, Catteau, Gregory, Chlibek, Roman, David, Marie Pierre, Richardus, Jan Hendrik, Lal, Himal, Oostvogels, Lidia, Pauksens, Karlis, Ravault, Stephanie, Rombo, Lars, Sonder, Gerard, Smetana, Jan, Heineman, Thomas, Bastidas, Adriana
Publicado no Hum Vaccin Immunother (2018)

Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis f...

Por Garland, Suzanne M., Paavonen, Jorma, Jaisamrarn, Unnop, Naud, Paulo, Salmerón, Jorge, Chow, Song‐Nan, Apter, Dan, Castellsagué, Xavier, Teixeira, Júlio C., Skinner, S. Rachel, Hedrick, James, Limson, Genara, Schwarz, Tino F., Poppe, Willy A.J., Bosch, F. Xavier, de Carvalho, Newton S., Germar, Maria Julieta V., Peters, Klaus, Del Rosario‐Raymundo, M. Rowena, Catteau, Grégory, Descamps, Dominique, Struyf, Frank, Lehtinen, Matti, Dubin, Gary
Publicado no Int J Cancer (2016)